4//SEC Filing
DelMar Pharmaceuticals, Inc. 4
Accession 0001213900-16-017306
$HURACIK 0001498382operating
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 2:14 PM ET
Size
4.8 KB
Accession
0001213900-16-017306
Insider Transaction Report
Form 4
BACHA JEFFREY
CEO and President10% Owner
Transactions
- Other
Common Stock
2016-10-03$3.20/sh+176$563→ 34,793 total
Footnotes (1)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001498382
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 2:14 PM ET
- Size
- 4.8 KB